- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06394102
Visual Health Evaluation of Natural Color Display Technology
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Beijing Tongren Hospitol,Capital Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult population, regardless of gender
- Refractive error is less than or equal to -2.5D and both eyes achieve corrected visual acuity of 0.8 or higher.
- Normal intraocular pressure with no organic pathology.
- No apparent symptoms of dry eye.
- Willing to cooperate to complete all the tests.
- Voluntarily signing the informed consent form.
Exclusion Criteria:
1: Individuals with strabismus and amblyopia exist.
2: Suffering from congenital eye conditions such as congenital cataracts or congenital retinal diseases.
3: Those who have undergone intraocular surgery (such as cataract removal, intraocular lens implantation, etc.).
4: Individuals with refractive media opacity (such as corneal lesions, lens opacity, etc.).
5: Abnormal intraocular pressure (IOP) (IOP < 10 mmHg or IOP > 21 mmHg, or a bilateral IOP difference of ≥5 mmHg).
6: Only one eye meets the inclusion criteria.
7: Active corneal infections such as bacterial, fungal, viral, or other acute or chronic anterior segment inflammations.
8: Currently using medications that may lead to dry eye or affect vision and corneal curvature.
9: Other ocular conditions, such as dacryocystitis, eyelid disorders and abnormalities, abnormal intraocular pressure, and glaucoma.
10: Unable to undergo regular eye examinations.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A Group
Is a group that accepts natural color mode processing and then accepts natural color mode closing.
In this group, subjects will first be exposed to an environment using a natural color pattern, which applies a specific light source to adjust the color temperature of the ambient light, and the phone color temperature will change with the ambient light color temperature.
To evaluate the effects of natural color patterns on visual fatigue and visual function, including but not limited to measures of adjustment function, assembly function, reading efficiency, blink detection, and retinal fundus blood flow.
|
A program mode on a terminal display device that reduces the difference between the color temperature of the ambient light and that of the display device.
Other Names:
|
|
Experimental: B Group
Is the group that accepts the natural color mode off first, and then accepts the natural color mode on.
In group B, the subjects will first be in the condition of changing ambient light, and the color temperature of the phone will not change with the ambient light color temperature.
Then the experiment was performed on different days to open the natural color mode.
The aim is to provide a benchmark against which to compare the effects of natural color pattern treatment in the experimental group.
|
A program mode on a terminal display device that reduces the difference between the color temperature of the ambient light and that of the display device.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual fatigue
Time Frame: Each participant will complete the visual fatigue questionnaire, followed immediately by a VEP task, and then re-assess visual fatigue immediately afterward. This sequence will occur twice per group, totaling four assessments per participant.
|
The visual fatigue questionnaire utilized in this study consists of a self-report survey with a total of 19 items.
It is designed to comprehensively assess the severity of visual fatigue symptoms, with a scoring system ranging from 1 to 7. Higher scores indicate more severe symptoms, encompassing three primary domains: ocular symptoms, visual discomfort, and psychological aspects triggered by visual fatigue.
|
Each participant will complete the visual fatigue questionnaire, followed immediately by a VEP task, and then re-assess visual fatigue immediately afterward. This sequence will occur twice per group, totaling four assessments per participant.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of Accommodative Sensitivity with Flip-Chart Post-VEP Tasks
Time Frame: Each participant will have three measurements: a baseline, and two post-VEP tasks, with immediate flip-chart tests after each task.
|
This clinical study involves the assessment of accommodative sensitivity for both monocular and binocular vision using a flip-chart immediately following each visual evoked potential (VEP) task.
The measurement will quantify the number of optotypes correctly identified within one minute, indicative of the subject's accommodative capacity.
|
Each participant will have three measurements: a baseline, and two post-VEP tasks, with immediate flip-chart tests after each task.
|
|
AC/A Ratio Measurement Post-VEP Tasks
Time Frame: Each participant will undergo three AC/A ratio measurements: at baseline and immediately after each of two VEP tasks.
|
This study involves the measurement of the AC/A ratio, which is a critical parameter in binocular vision assessment, reflecting the relationship between accommodation (focus adjustment) and convergence (ocular alignment).
The AC/A ratio will be determined using the prism bar technique, which involve adding lenses to stimulate accommodation and measuring the resulting changes in convergence.
|
Each participant will undergo three AC/A ratio measurements: at baseline and immediately after each of two VEP tasks.
|
|
Ocular Fundus Blood Flow
Time Frame: Retinal blood flow measurements should be taken within 3 minutes after the completion of each visual evoked potential (VEP) task. There are two VEP tasks per group, along with a baseline measurement, resulting in a total of three measurements.
|
The study measured the sub foveal choroidal thickness, superficial vessel complex (SVC) density, and deep vessel complex (DVC) density, analyzing changes in retinal blood flow under the two modes.
|
Retinal blood flow measurements should be taken within 3 minutes after the completion of each visual evoked potential (VEP) task. There are two VEP tasks per group, along with a baseline measurement, resulting in a total of three measurements.
|
|
Blink Frequency
Time Frame: Blink frequency 3 minutes after the start of each visual evoked task and 3 minutes before the end
|
Use electronic devices to record the number of clicks within 3 minutes and calculate the frequency.
|
Blink frequency 3 minutes after the start of each visual evoked task and 3 minutes before the end
|
|
Reading efficiency
Time Frame: The test was recorded 10 minutes after the start and 10 minutes before the end.
|
The number pairs were read in the first and last 10 minutes of the visual evoked task, and the number of number pairs read per minute was counted.
|
The test was recorded 10 minutes after the start and 10 minutes before the end.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TREC2023-KY120
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chromatic Adaptation
-
Taipei Medical University WanFang HospitalUnknownSister-chromatic-exchange(SCE) | Micronuclei(MN)Taiwan
-
Beijing Tongren HospitalCompletedLongitudinal Chromatic Aberration | Blue Light Defocus ManipulationChina
-
Pamukkale UniversityCompletedGynecologic Cancer | Chemotherapy Effect | Mobile Application | Physiological Adaptation | Psychosocial AdaptationTurkey
-
University of ZurichUnknown
-
University of CopenhagenCompleted
-
Hacettepe UniversityCompleted
-
PepsiCo Global R&DTerminatedSweetness Liking AdaptationUnited States
-
Amsterdam UMC, location VUmcDutch Cancer SocietyTerminatedAdaptation, EmotionalNetherlands
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Universidad Nacional de ColombiaCompleted